Best High Tech Stocks To Invest In Right Now

In the wake of the WannaCry cyberattack, investors are wondering which cybersecurity stocks to buy. Since the attack originated from instruments created by the U.S. government and President Trump has already shown that he is quite earnest about preventing cyberattacks, it’s a good bet that the U.S. government will spend billions of dollars on cybersecurity going forward.

Source: Shutterstock

Therefore, investors should look for stocks to buy that will benefit from this trend. Booz Allen Hamilton Holding Corporation (NYSE:BAH) and Palo Alto Networks Inc (NYSE:PANW) fit the bill.

Best High Tech Stocks To Invest In Right Now: Echelon Corporation(ELON)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Echelon Co. (NASDAQ:ELON) shares reached a new 52-week high and low during trading on Monday . The company traded as low as $4.07 and last traded at $4.18, with a volume of 9600 shares changing hands. The stock had previously closed at $4.31.

Best High Tech Stocks To Invest In Right Now: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internet Initiative Japan (IIJI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best High Tech Stocks To Invest In Right Now: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

Best High Tech Stocks To Invest In Right Now: 3D Systems Corporation(DDD)

Advisors’ Opinion:

  • [By Paul Ausick]

    Short interest in 3D Systems Corp. (NYSE: DDD) fell by 1.9% to 35.03 million shares. Some 32.1% of the company’s float was short. Days to cover rose from 12 to 15. In the two-week short interest period, the share price rose by 27.3%. The stock’s 52-week trading range is $7.92 to $23.70, and shares closed at $10.68 on Wednesday, up about 0.7% on the day.

  • [By Chris Lange]

    3D Systems Corp. (NYSE: DDD) is set to release its most recent quarterly results on Wednesday. The consensus forecast calls for breakeven earnings and $164.7 million in revenue. Shares closed on Friday at $12.05. The consensus price target is $9.83, and the 52-week range is $7.92 to $23.70.

  • [By Beth McKenna]

    As with last quarter, main rival 3D Systems(NYSE:DDD) is scheduled to report on the same day, though before the market opens.

    Shares of Stratasys are up 3.5% so far in 2018 through April 24. For context, the S&P 500 is down 1% in 2018, while 3D Systems stock has gained nearly 30% this year.

  • [By Beth McKenna]

    Diversified 3D printing company 3D Systems(NYSE:DDD) is slated to report its first-quarter 2018 earnings after the market closes on Wednesday, May 2. As with last quarter, main rivalStratasysis scheduled to report on the same day, though before the market opens.

  • [By Chris Lange]

    3D Systems Corp. (NYSE: DDD) is expected to post its most recent quarterly results Wednesday. The consensus forecast is $0.01 in EPS and $162.12 million in revenue. Shares ended the week at $10.14 apiece. The consensus price target is $9.72, and the 52-week range is $7.92 to $23.70.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on 3D Systems (DDD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best High Tech Stocks To Invest In Right Now: CatchMark Timber Trust, Inc.(CTT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CatchMark Timber Trust (CTT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com